NRX Pharmaceuticals, Inc. Adjustments to Additional Paid in Capital, Other
NRX Pharmaceuticals, Inc. (NRXP) reported Adjustments to Additional Paid in Capital, Other of $0 for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-16.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2021-05-14
- NRX Pharmaceuticals, Inc. adjustments to additional paid in capital, other for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- NRX Pharmaceuticals, Inc. adjustments to additional paid in capital, other for the quarter ending 2019-12-31 was $0.00.
- NRX Pharmaceuticals, Inc. adjustments to additional paid in capital, other for the quarter ending 2019-09-30 was $88.79K.
- NRX Pharmaceuticals, Inc. adjustments to additional paid in capital, other for the quarter ending 2019-06-30 was $191.21K.
- NRX Pharmaceuticals, Inc. adjustments to additional paid in capital, other for fiscal 2019 was $280.00K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|---|
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 10-Q · filed 2020-11-16 | ||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-14 | |||
| 2019-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-14 | $88.79K derived: sum of 2 quarters · filed 2021-05-14 | $280.00K derived: sum of 3 quarters · filed 2021-05-14 | $280.00K 10-K/A · filed 2021-05-14 |
| 2019-09-30 | $88.79K 10-Q · filed 2020-11-16 | $280.00K derived: sum of 2 quarters · filed 2020-11-16 | $280.00K 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $191.21K 10-Q · filed 2020-11-16 | $191.21K 10-Q · filed 2020-08-14 | ||
| 2017-12-31 | $100.00 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |